NCI Official Says Public Health Issue As Important As Data In Mammography
In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award
Generic Drug Makers Set Sights In Taxol Worldwide Market
Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain
White House Order Poses Difficulties For NIH Peer Review
NCI Cancer Education Program To Open To Innovative Ideas
NCI To Hold Symposium To Honor Wener Kirsten
AACR honors Five With Awards Next Month
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









